Evidence map›Paper›PMID 28616822›Full record

SynthesisStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2017

A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy : A systematic review by the Italian Head and Neck Radiotherapy Study Group.

Stefano Ursino, Elisa D'Angelo, Rosario Mazzola, Anna Merlotti, Riccardo Morganti, Agostino Cristaudo, Fabiola Paiar, Daniela Musio, Daniela Alterio, Almalina Bacigalupo and 2 more

Open access · greenAbstract readComparative StudySystematic Review
PubMed Publisher
In one paragraph

Synthesis in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Outcome and toxicity of intensity-modulated radiotherapy with simultaneous integrated boost in patients with pharyngo-laryngeal cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Radiotherapy-induced dysphagia and its impact on quality of life in patients with nasopharyngeal carcinoma.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2019
    Article
  12. Article
  13. Article
  14. Patient positioning in head and neck cancer : Setup variations and safety margins in helical tomotherapy.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2018
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 2 countries.

Stefano UrsinoRadiation Oncology, University Hospital S. Chiara, Via Roma 55, 56126, Pisa, Italy. stefano.ursino@med.unipi.it.ORCID http://orcid.org/0000-0003-3018-2338
Elisa D'AngeloRadiation Oncology, University Hospital, Largo del Pozzo 74, 44125, Modena, Italy.
Rosario MazzolaRadiation Oncology, Sacro Cuore-Don Calabria Cancer Care Center, Via Don Sempreboni 5, 37024, Negrar-Verona, Italy.
Anna MerlottiRadiation Oncology, S.Croce e Carle Hospital, Via M. Coppino 26, 12100, Cuneo, Italy.
Riccardo MorgantiRadiation Oncology, University Hospital S. Chiara, Via Roma 55, 56126, Pisa, Italy.
Agostino CristaudoRadiation Oncology, University Hospital S. Chiara, Via Roma 55, 56126, Pisa, Italy.
Fabiola PaiarRadiation Oncology, University Hospital S. Chiara, Via Roma 55, 56126, Pisa, Italy.
Daniela MusioRadiation Oncology, University Hospital La Sapienza, Viale del Policlinico 155, 00161, Roma, Italy.
Daniela AlterioRadiation Oncology, Advanced Radiotherapy Center, European Institute of Oncology, Via G. Ripamonti 435, 20141, Milan, Italy.
Almalina BacigalupoRadiation Oncology, AOU IRCCS San Martino - IST National Cancer Research Institute and University, Largo Rosanna Benzi 10, 16132, Genoa, Italy.
Elvio Grazioso RussiRadiation Oncology, S.Croce e Carle Hospital, Via M. Coppino 26, 12100, Cuneo, Italy.
Frank LohrRadiation Oncology, University Hospital, Largo del Pozzo 74, 44125, Modena, Italy.
Ospedale Santa Chiara · ITCTO Hospital · ITUniversity of Modena and Reggio Emilia · ITOspedale Policlinico San Martino · ITOspedale Sacro Cuore Don Calabria · ITPoliclinico Umberto I · ITRipamonti · ITUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDysphagia is one of the most important treatment-related side effects in head and neck cancer (HNC), as it can lead to severe life-threating complications such as aspiration pneumonia and malnutrition. Intensity-modulated radiotherapy (IMRT) could reduce swallowing dysfunction by producing a concave dose distribution and reducing doses to the swallowing-related organs at risk (SWOARs). The aim of this study was to review the current literature in order to compare swallowing outcomes between IMRT and three-dimensional conformal radiotherapy (3DCRT).

methodsA search was conducted in the PubMed and Embase databases to identify studies on swallowing outcomes, both clinically and/or instrumentally assessed, after 3DCRT and IMRT. Dysphagia-specific quality of life and objective instrumental data are summarized and discussed.

resultsA total of 262 papers were retrieved from the searched databases. An additional 23 papers were retrieved by hand-searching the reference lists. Ultimately, 22 papers were identified which discussed swallowing outcomes after 3DCRT and IMRT for HNC. No outcomes from randomized trials were identified.

conclusionDespite several methodological limitations, reports from the current literature seem to suggest better swallowing outcomes with IMRT compared to 3DCRT. Further improvements are likely to result from the increased use of IMRT plans optimized for SWOAR sparing.

Indexed as

Carcinoma, Squamous CellDeglutitionDeglutition DisordersHumansOrgans at RiskOtorhinolaryngologic NeoplasmsRadiation InjuriesRadiotherapy, ConformalRadiotherapy DosageRadiotherapy, Intensity-ModulatedTreatment OutcomeChemotherapyDysphagiaOrgans at riskPneumonia, aspirationQuality of life

Identifiers

PMID28616822
OpenAlexW2768691418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.